BioAtla (BCAB) Retained Earnings (2020 - 2026)
BioAtla's (BCAB) quarterly Retained Earnings came in at -$552.0 million in Q1 2026, down 10.1% year-on-year from -$614.0 million in Q1 2025, and down 208.35% quarter-over-quarter from $509.5 million in Q4 2025.
BioAtla (BCAB) Retained Earnings (2020 - 2026) Analysis & Trends
BioAtla's Retained Earnings history runs 7 years deep, the most recent figure standing at -$552.0 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 10.1% year-over-year to -$552.0 million in Q1 2026; TTM through Mar 2026 was -$552.0 million, a 10.1% decrease from a year earlier, with the FY2025 full-year figure at $509.5 million, up 1.83% from the prior year.
- Retained Earnings fell to -$552.0 million in Q1 2026 per BCAB's latest filing, from $509.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at $509.5 million in Q4 2025 and bottomed at -$552.0 million in Q1 2026.
- The 5-year median for Retained Earnings is $480.5 million (2023), against an average of $135.7 million.
- Across the five-year window, Retained Earnings plunged 173.73% in 2022 and jumped 300.65% in 2023, its largest moves.
- Year by year, Retained Earnings stood at -$292.8 million in 2022, then jumped by 266.3% to $486.9 million in 2023, then climbed by 2.75% to $500.3 million in 2024, then grew by 1.83% to $509.5 million in 2025, then slumped by 208.35% to -$552.0 million in 2026.
- Per Business Quant, the three latest BCAB Retained Earnings figures stand at -$552.0 million (Q1 2026), $509.5 million (Q4 2025), and $504.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - | -551.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -551.99 Mn |
| Dec 31, 2025 | 509.46 Mn |
| Sep 30, 2025 | 504.62 Mn |
| Jun 30, 2025 | 503.33 Mn |
| Mar 31, 2025 | -501.37 Mn |
| Dec 31, 2024 | 500.30 Mn |
| Sep 30, 2024 | 494.12 Mn |
| Jun 30, 2024 | 491.93 Mn |
| Mar 31, 2024 | -439.50 Mn |
| Dec 31, 2023 | 486.93 Mn |
| Sep 30, 2023 | 484.04 Mn |
| Jun 30, 2023 | 480.52 Mn |
| Mar 31, 2023 | -320.26 Mn |
| Dec 31, 2022 | -292.80 Mn |
| Sep 30, 2022 | 407.89 Mn |
| Jun 30, 2022 | -239.48 Mn |
| Mar 31, 2022 | -210.60 Mn |
| Dec 31, 2021 | 397.14 Mn |
| Sep 30, 2021 | 393.58 Mn |
| Jun 30, 2021 | -140.00 Mn |